APA (7th ed.) Citation

R, S., A, A., MI, P., A, K., & R, G. (2026). Mavacamten in Obstructive Hypertrophic Cardiomyopathy and C282Y Homozygous Hereditary Hemochromatosis: A First-in-Human Report. JACC. Case reports, 31(18), 107736. https://doi.org/10.1016/j.jaccas.2026.107736

Chicago Style (17th ed.) Citation

R, Sam, Ananthaneni A, Planek MI, Kogan A, and Gordon R. "Mavacamten in Obstructive Hypertrophic Cardiomyopathy and C282Y Homozygous Hereditary Hemochromatosis: A First-in-Human Report." JACC. Case Reports 31, no. 18 (2026): 107736. https://doi.org/10.1016/j.jaccas.2026.107736.

MLA (9th ed.) Citation

R, Sam, et al. "Mavacamten in Obstructive Hypertrophic Cardiomyopathy and C282Y Homozygous Hereditary Hemochromatosis: A First-in-Human Report." JACC. Case Reports, vol. 31, no. 18, 2026, p. 107736, https://doi.org/10.1016/j.jaccas.2026.107736.